Skip to main content
OpenTrials

Clinical trial condition

mCRPC (Metastatic Castration-resistant Prostate Cancer)

Explore clinical trials studying mCRPC (Metastatic Castration-resistant Prostate Cancer). Study availability and eligibility vary by location and protocol.

14 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

mCRPC (Metastatic Castration-resistant Prostate Cancer) trial results

Recruiting

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT07719361

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +15 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START New Jersey East Brunswick, New Jersey, United States
View Trial Details
Recruiting

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

NCT06844383

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Masonic Cancer Center Minneapolis, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

NCT07103018

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +18 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 13 locations
View Trial Details
Recruiting

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

NCT05283330

Conditions
Astrocytoma, Breast Cancer, Breast Diseases, +58 more
Locations
  • Northwestern University Robert H Lurie Medical Research Chicago, Illinois, United States
  • University of Iowa Health Care Iowa City, Iowa, United States
  • UK Markey Cancer Center Lexington, Kentucky, United States
  • Advanced Molecular Imaging and Therapy Glen Burnie, Maryland, United States
View Trial Details
Recruiting

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

NCT06785636

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • MemorialCare Orange Coast Medical Center Fountain Valley, California, United States
  • Cancer and Blood Research Center Los Alamitos, California, United States
  • University of Colorado Health Aurora, Colorado, United States
  • Mount Sinai Medical Center Miami, Florida, United States
View all 18 locations
View Trial Details
Recruiting

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

NCT06190899

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Centre Jean Perrin Clermont-Ferrand, France
  • Institut Paoli-Calmettes Marseille, France
  • Centre Antoine Lacassagne Nice, France
View all 13 locations
View Trial Details
Recruiting

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

NCT06801236

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
Locations
  • University of California San Diego, Moores Cancer Center La Jolla, California, United States
  • Moffitt Cancer Center, Tampa Tampa, Florida, United States
  • University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
  • Harvard Medical School-Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions